Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy OncoCyte Corporation stock | $3.34

Learn how to easily invest in OncoCyte Corporation stock.

OncoCyte Corporation is a biotechnology business based in the US. OncoCyte Corporation shares (OCX) are listed on the NASDAQ and all prices are listed in US Dollars. OncoCyte Corporation employs 51 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in OncoCyte Corporation

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – OCX – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

OncoCyte Corporation stock price (NASDAQ: OCX)

Use our graph to track the performance of OCX stocks over time.

OncoCyte Corporation shares at a glance

Information last updated 2021-10-16.
Latest market close$3.34
52-week range$1.41 - $6.57
50-day moving average $3.75
200-day moving average $4.64
Wall St. target price$9.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.36

Buy OncoCyte Corporation shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
$20 per year
Financial advice powered by relationships, not commissions.
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy OncoCyte Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

OncoCyte Corporation price performance over time

Historical closes compared with the close of $3.34 from 2021-10-20

1 week (2021-10-14) -2.62%
1 month (2021-09-21) -13.70%
3 months (2021-07-21) -40.04%
6 months (2021-04-21) -24.77%
1 year (2020-10-21) 110.06%
2 years (2019-10-21) 102.42%
3 years (2018-10-19) 78.61%
5 years (2016-10-21) 4.3

OncoCyte Corporation financials

Revenue TTM $4.2 million
Gross profit TTM $-639,000
Return on assets TTM -18.06%
Return on equity TTM -38.67%
Profit margin 0%
Book value $1.14
Market capitalisation $315 million

TTM: trailing 12 months

Shorting OncoCyte Corporation shares

There are currently 2.3 million OncoCyte Corporation shares held short by investors – that's known as OncoCyte Corporation's "short interest". This figure is 7.8% down from 2.5 million last month.

There are a few different ways that this level of interest in shorting OncoCyte Corporation shares can be evaluated.

OncoCyte Corporation's "short interest ratio" (SIR)

OncoCyte Corporation's "short interest ratio" (SIR) is the quantity of OncoCyte Corporation shares currently shorted divided by the average quantity of OncoCyte Corporation shares traded daily (recently around 499132.17391304). OncoCyte Corporation's SIR currently stands at 4.6. In other words for every 100,000 OncoCyte Corporation shares traded daily on the market, roughly 4600 shares are currently held short.

However OncoCyte Corporation's short interest can also be evaluated against the total number of OncoCyte Corporation shares, or, against the total number of tradable OncoCyte Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case OncoCyte Corporation's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 OncoCyte Corporation shares in existence, roughly 20 shares are currently held short) or 0.0433% of the tradable shares (for every 100,000 tradable OncoCyte Corporation shares, roughly 43 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against OncoCyte Corporation.

Find out more about how you can short OncoCyte Corporation stock.

OncoCyte Corporation share dividends

We're not expecting OncoCyte Corporation to pay a dividend over the next 12 months.

OncoCyte Corporation share price volatility

Over the last 12 months, OncoCyte Corporation's shares have ranged in value from as little as $1.41 up to $6.57. A popular way to gauge a stock's volatility is its "beta".

OCX.US volatility(beta: 1.91)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while OncoCyte Corporation's is 1.9116. This would suggest that OncoCyte Corporation's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

OncoCyte Corporation overview

OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay. It also provides custom drug target discovery; assay design, development, and validation; and clinical trial and other testing services for pharmaceutical companies. OncoCyte Corporation has a strategic collaboration with Gruppo Oncologico del Nord-Ovest of Pisa to evaluate DetermaIO as a biomarker for immunotherapy response in metastatic colorectal cancer; and Echelon Diagnostics, Inc. The company was founded in 2009 and is headquartered in Irvine, California. .

Frequently asked questions

What percentage of OncoCyte Corporation is owned by insiders or institutions?
Currently 10.329% of OncoCyte Corporation shares are held by insiders and 63.54% by institutions.
How many people work for OncoCyte Corporation?
Latest data suggests 51 work at OncoCyte Corporation.
When does the fiscal year end for OncoCyte Corporation?
OncoCyte Corporation's fiscal year ends in December.
Where is OncoCyte Corporation based?
OncoCyte Corporation's address is: 15 Cushing, Irvine, CA, United States, 92618
What is OncoCyte Corporation's ISIN number?
OncoCyte Corporation's international securities identification number is: US68235C1071
What is OncoCyte Corporation's CUSIP number?
OncoCyte Corporation's Committee on Uniform Securities Identification Procedures number is: 68235C107

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site